Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Pyocycanin, a Contributory Factor in Haem Acquisition and Virulence Enhancement of Porphyromonas gingivalis in the Lung

  • Malgorzata Benedyk,

    Affiliation Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

  • Dominic P. Byrne,

    Affiliation Department of Biochemistry and Cell Biology, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom

  • Izabela Glowczyk,

    Affiliation Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

  • Jan Potempa,

    Affiliations Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland, Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, United States of America

  • Mariusz Olczak,

    Affiliation Faculty of Biotechnology, Laboratory of Biochemistry, University of Wroclaw, Wroclaw, Poland

  • Teresa Olczak,

    Affiliation Faculty of Biotechnology, Laboratory of Biochemistry, University of Wroclaw, Wroclaw, Poland

  • John W. Smalley

    josmall@liv.ac.uk

    Affiliation School of Dentistry, University of Liverpool, Liverpool, United Kingdom

Correction

25 Jan 2016: Benedyk M, Byrne DP, Glowczyk I, Potempa J, Olczak M, et al. (2016) Correction: Pyocycanin, a Contributory Factor in Haem Acquisition and Virulence Enhancement of Porphyromonas gingivalis in the Lung. PLOS ONE 11(1): e0148008. https://doi.org/10.1371/journal.pone.0148008 View correction

Abstract

Several recent studies show that the lungs infected with Pseudomonas aeruginosa are often co-colonised by oral bacteria including black-pigmenting anaerobic (BPA) Porphyromonas species. The BPAs have an absolute haem requirement and their presence in the infected lung indicates that sufficient haem, a virulence up-regulator in BPAs, must be present to support growth. Haemoglobin from micro-bleeds occurring during infection is the most likely source of haem in the lung. Porphyromonas gingivalis displays a novel haem acquisition paradigm whereby haemoglobin must be firstly oxidised to methaemoglobin, facilitating haem release, either by gingipain proteolysis or capture via the haem-binding haemophore HmuY. P. aeruginosa produces the blue phenazine redox compound, pyocyanin. Since phenazines can oxidise haemoglobin, it follows that pyocyanin may also facilitate haem acquisition by promoting methaemoglobin production. Here we show that pyocyanin at concentrations found in the CF lung during P. aeruginosa infections rapidly oxidises oxyhaemoglobin in a dose-dependent manner. We demonstrate that methaemoglobin formed by pyocyanin is also susceptible to proteolysis by P. gingivalis Kgp gingipain and neutrophil elastase, thus releasing haem. Importantly, co-incubation of oxyhaemoglobin with pyocyanin facilitates haem pickup from the resulting methemoglobin by the P. gingivalis HmuY haemophore. Mice intra-tracheally challenged with viable P. gingivalis cells plus pyocyanin displayed increased mortality compared to those administered P. gingivalis alone. Pyocyanin significantly elevated both methaemoglobin and total haem levels in homogenates of mouse lungs and increased the level of arginine-specific gingipain activity from mice inoculated with viable P. gingivalis cells plus pyocyanin compared with mice inoculated with P. gingivalis only. These findings indicate that pyocyanin, by promoting haem availability through methaemoglobin formation and stimulating of gingipain production, may contribute to virulence of P. gingivalis and disease severity when co-infecting with P. aeruginosa in the lung.

Introduction

Pseudomonas aeruginosa is one of the major bacterial causes of respiratory infections- in patients with cystic fibrosis (CF), and contributes to acute exacerbations of chronic obstructive pulmonary disease, or bronchiectasis [16]. Amongst these, CF lung infections are often used as a model system from which one can gain insight into other respiratory infections more generally. In individuals with CF, defects in the CF trans-membrane conductance regulator gene lead to chloride retention and results in abnormally high viscosity of the mucus coating the lung epithelium. This in turn leads to impairment of the mucociliary escalator and the chronic colonisation of the mucous secretions by a number of aerobic and facultatively anaerobic bacterial species, including Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa and Burkholderia cenocepacia [1]. It is thought that rapid depletion of oxygen, resulting from metabolism by aerobic, facultatively anaerobic species and neutrophils, coupled with the highly viscous nature of the mucous secretions which impedes gas diffusion, help to create micro-environments which are conducive to the growth of a wide range of anaerobic species in the CF lung. Indeed, in recent years our understanding of bacterial infections has changed considerably, pointing to the likelihood that anaerobes may also play an important contributory role in lung infections. For example, in some CF patients with P. aeruginosa lung infections, anaerobes are found in numbers equal to, or exceeding those of the pseudomonads [7, 8]. Many of the anaerobes isolated from CF lungs infected with P. aeruginosa are normally residents of the oral cavity where they are found in sub-gingival plaque and periodontal pockets. They include members of the black-pigmenting anaerobes (BPAs) belonging to the genera Porphyromonas and Prevotella, including the species Porphyromonas gingivalis and Prevotella intermedia which have been detected by both cultural and more precise DNA-based methods, including RFLP and pyrosequencing [712]. The BPAs, which are major aetiological agents in the development and progression of periodontitis [13], express a large number of virulence factors [14] and have an absolute requirement for haem. Animal studies have also shown that haem up-regulates the pathogenicity of P. gingivalis through mechanisms including increased levels of arginine-specific gingipain proteases (Rgps) which are major virulence factors of this organism [1517]. Growth on blood-containing media leads to cell-surface accumulation of haem in either the monomeric form (haematin) in the case of Prevotella nigrescens and P. intermedia [18] and as the μ-oxo bis haem (dimeric form) in the case of P. gingivalis [19]. Given the absolute haem requirements of black-pigmenting anaerobes, the fact that these species are found in high numbers in CF sputum points to a sufficiency of haem to support their growth and to enable them to avoid detection and eradication from the lung by the host. The major haem source for these species in their oral habitats (the inflamed gingival sulcus and periodontal pocket) is haemoglobin. Micro-bleeds due to inflammatory damage to the delicate epithelium result in the presence of erythrocytes in the CF lung and P. aeruginosa is capable of liberating haemoglobin from these cells via production of haemolysins [20,21].

The BPAs display a novel haem acquisition paradigm whereby oxyhaemoglobin is firstly oxidised to the methaemoglobin state [2224]. In P. gingivalis this mechanism is mediated by the Rgps [22,23], and in P. intermedia by the protease interpain A (InpA) [24]. In the case of P. gingivalis, the more susceptible methaemoglobin substrate can be then fully proteolysed by the lysine-specific gingipain (Kgp) to release free haem [22,23]. Haem can also be extracted from methaemoglobin by the HmuY haemophore for subsequent delivery to the bacterial cell surface [2528]. In addition, there is evidence that P. intermedia may help to support the growth of P. gingivalis by proteolytically promoting methaemoglobin formation for subsequent haem extraction by the HmuY haemophore [29]. Moreover, in the CF lung, proteases originating not only from bacteria, but also those produced by the host are considered to play an important pathophysiological role during infection. The majority of proteolytic activity originates from neutrophils [30], with neutrophil elastase the most abundant, and which has been detected in micromolar levels in bronchoalveolar lavage fluid of children with either bacterial or viral respiratory infections [31]. Recently, Cosgrove et al. [32] demonstrated that neutrophil as well Pseudomonas elastase can degrade haemoglobin, pointing to the possibility that these may be a significant factors in elevating the haem concentrations in the CF lung to levels which could support the growth of BPAs.

P. aeruginosa produces the blue pigment pyocyanin, a redox active phenazine compound, which displays a number of biological activities which are considered important in P. aeruginosa infections [33,34]. These include inhibition of the beating of cilia and hence perturbation of the mucociliary escalator [35,36]. Repeated administration of pyocyanin into the lungs of mice has been shown to cause a number of pathological changes including airway fibrosis, goblet cell hyperplasia and metaplasia, and destruction of the alveolar airspaces [37]. Pyocyanin colours blue the sputum of CF patients infected with P. aeruginosa, where it is found at average concentrations of 16 μg/ml (80 μM) [38]. Moreover, pyocyanin in its blue (oxidised) form when extracted from the sputum of both bronchiectasis and CF patients colonised by P. aeruginosa is bioavailable since it can inactivate ciliary beating in vitro [38]. From a clinical perspective, isolates of a highly virulent strain of P. aeruginosa infecting CF patients (known as the Liverpool Epidemic Strain [LES]) are typified by their over-production of pyocyanin (relative to clinical non-epidemic isolates and environmental strains), the levels of which can reach as high as 40 μM in in vitro cultures [39]. Importantly, Mowat et al. [2] have demonstrated that the presence of such P. aeruginosa pyocyanin over-producing strains correlates with exacerbations of CF pulmonary infection. In the leuko (reduced) form, pyocyanin can help to supply iron for P. aeruginosa by facilitating its release from transferrin [40,41]. However, in the oxidised form one significant biochemical property which has been observed for phenazine methosulphate is the ability to oxidise haemoglobin, forming both methaemoglobin and the higher oxidation state species ferrylhaemoglobin [42]. Given the above-mentioned haem acquisition paradigm displayed by BPAs, it follows that haemoglobin oxidation in the lung brought about by the phenazine pyocyanin, i.e. as a result of production by P. aeruginosa, may feature as an important first step in haem acquisition and in promoting virulence of co-colonising Prevotella and Porphyromonas species in the lung [7,8].

Of the BPAs, P. gingivalis is the best characterised with respect to its virulence properties and haem acquisition system. It is a known cause of respiratory infections [43] and animal lung infection pathogenicity models using this organism are well documented [44]. Accordingly, the possible virulence-enhancing effects of pyocyanin on P. gingivalis were explored with regard to its potential role in haem acquisition by employing the well-established mouse lung model [44]. Clearly whilst P. aeruginosa would be the source of any pyocyanin in the lung, we used in this study a mono-infection with P. gingivalis (plus or minus pyocyanin) to avoid any pathogenic effects arising from other redox or virulence agents produced by P. aeruginosa itself. In such a system, pyocyanin-mediated oxidation of oxyhaemoglobin in the lung during infectious challenge with P. gingivalis should lead to an increased levels of methaemoglobin and subsequently to a greater abundance of haem to support growth and up-regulate the virulence. Indeed, in this paper we show that pyocyanin can bring about methaemoglobin formation and facilitate haemoglobin degradation by neutrophil elastase and the P. gingivalis Kgp gingipain, as well as haem pickup by the HmuY haemophore. We also show that mice challenged with P. gingivalis plus pyocyanin display highly increased mortality compared to those challenged with P. gingivalis only. In line with our haem acquisition paradigm, we also demonstrate increased levels of both methaemoglobin and total haem in lung tissues during infection with P. gingivalis in the presence of pyocyanin.

Results

Oxyhaemoglobin oxidation by pyocyanin

The ability of pyocyanin to oxidise oxyhaemoglobin to methaemoglobin was tested over a concentration range which has been observed in sputa from patients infected with P. aeruginosa [38]. A typical set of time-dependent spectra is shown in Fig. 1A for oxyhaemoglobin incubated with 20 μM pyocyanin. These spectra displayed decreases in the absorbance of the Q bands at both 540 and 576 nm and increases at 500 and 630 nm, which are typical of the formation of methaemoglobin [45]. This was also accompanied by a blue shift in the Soret band from 414 to 405 nm (Fig. 1B). Isosbestic points were present at 410, 475, 523, and 590 nm showing that the oxyhaemoglobin had been transformed into methaemoglobin directly. When sodium dithionite (to 10 mM final concentration) was added to haemoglobin-pyocyanin incubation mixtures to concomitantly reduce the haem iron and deplete dissolved oxygen, a spectrum was generated with a 429 nm Soret and a 555 nm visible band, which is typical of deoxyhaemoglobin (data not shown). This demonstrated that methaemoglobin had originally been produced by the action of the pyocyanin on oxyhaemoglobin. Measurement of the change in A576 to determine the rate of oxyhaemoglobin depletion [46] revealed that the range of concentrations of pyocyanin, which might be encountered in the CF lung during P. aeruginosa infection, affected rapid methaemoglobin formation (Fig. 1C). The initial oxidation rates calculated by linear regression analysis over the first hour of reaction showed that even the lowest pyocyanin concentration tested (5 μM) brought about an oxidation rate 5-fold that of natural auto-oxidation, whilst this increased to 25-fold for the mid-range concentration of 50 μM pyocyanin, and was 40-fold greater for 100 μM pyocyanin (Table 1). In addition, the rate of methaemoglobin formation brought about by 50 μM pyocyanin was approximately 8-fold greater than that brought about by 50 μM mM NaNO2 (3.2 ± 0.07 min-1×10–4), which rapidly oxidises oxyhaemoglobin [47].

thumbnail
Fig 1. Oxidation of oxyhaemoglobin by pyocyanin.

Q band (A) and Soret band (B) regions of oxyhaemoglobin (4 μM with respect to tetramer) during incubation with 20 μM pyocyanin. Buffer was 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5. Reaction was carried out at 37°C. Arrows in panel A denote changes in extinction with time related to methaemoglobin formation. The spectra were corrected for the absorbance contribution due to pyocyanin. (C) Rates of oxyhaemoglobin oxidation mediated by pyocyanin (5 to 100 μM). Oxidation rates were calculated as the ratio of the concentration of oxyhaemoglobin at time zero ([HbO2]t0) compared to that at time t ([HbO2]t), as a function of the change in A576 as described by Tsuruga and Shikama [35]. Control oxyHb, oxyhaemoglobin auto-oxidation.

https://doi.org/10.1371/journal.pone.0118319.g001

thumbnail
Table 1. Oxyhaemoglobin oxidation rates in the presence of pyocyanin.

https://doi.org/10.1371/journal.pone.0118319.t001

Oxyhaemoglobin (HbO2) oxidation was calculated as the ratio of the concentration of oxyhaemoglobin at time zero ([HbO2]t0]) compared to that at time t ([HbO2]t) as a function of the change in A576 as described by Tsuruga and Shikama [42]. Rates were calculated from the data shown in Fig. 1 using linear regression (GraphPad Prism) over the first hour of the reaction. The initial oxyhaemoglobin concentration was 4 μM and incubations were carried out at 37°C in 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5.

Formation of HmuY-ferrihaem complex during co-incubation of oxyhaemoglobin with HmuY in the presence of pyocyanin

Given that oxyhaemoglobin oxidation is a pre-requisite step in both P. gingivalis gingipain-mediated haemoglobin breakdown and subsequent haem release, and the direct pickup of iron(III) protoporphyrin IX by the HmuY haemophore [22,23,28,29], it follows that agents present in the lung promoting methaemoglobin formation could facilitate both these processes and aid haem acquisition. Accordingly, the effect of co-incubating oxyhaemoglobin with HmuY in the presence of pyocyanin was examined. As seen in Fig. 2, after 24-h incubation the presence of the HmuY-ferrihaem complex was indicated by a prominent absorbance at 525 nm plus shoulder at 558 nm (green line), the positions of these bands being confirmed by producing second derivatives of the spectrum (data not shown). In comparison, these signature bands of the HmuY-ferrihaem complex were not observed in the absence of pyocyanin (black line), even after 24-h incubation. It is noteworthy that not all the haem was transferred to the HmuY after 24 h since the absorbance in the Q band region around 630 nm (Fig. 2, green line) indicated the presence of some residual methaemoglobin.

thumbnail
Fig 2. Formation of the HmuY-ferrihaem complex during co-incubation of oxyhaemoglobin with the P. gingivalis HmuY haemophore in the presence of pyocyanin.

HmuY and pyocyanin concentrations were 32 and 50 μM, respectively, whilst that of oxyhaemoglobin was 4 μM (with respect to tetramer). Buffer was 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5. Arrows indicate the 525 nm Q band plus 558 nm shoulder related to the presence of the HmuY-ferrihaem complex, green line; oxyhaemoglobin at time zero, red line; oxyhaemoglobin plus HmuY, black line.

https://doi.org/10.1371/journal.pone.0118319.g002

We have previously used non-denaturing PAGE followed by haem staining with TMB-H2O2 and protein staining with Coomassie Brilliant Blue (CBB) to visualise the time-dependent redistribution of haem between methaemoglobin and HmuY [28]. The pickup of haem by the haemophore is accompanied by an increase in electrophoretic mobility which is attributed to the increase in negative charge imparted to the HmuY-haem complex by the iron porphyrin carboxylates [28]. We therefore examined the effect of pyocyanin (100 μM) on haem pickup by HmuY during co-incubation with oxyhaemoglobin. As shown in Fig. 3, there was a gradual time-dependent decrease in TMB-H2O2 staining of the haemoglobin during incubation with pyocyanin. This was accompanied by an increase in haem staining associated with the HmuY showing haem transfer to the haemophore. In addition, in keeping with previous observations, there was a notable loss of protein staining of the haemoglobin chains with time [23], which is attributable to the loss of structural integrity through alpha helix unfolding [48,49] as a consequence of haem removal [50,51]. The haem staining associated with the haemoglobin chains even after 24-h incubation of haemoglobin plus HmuY and pyocyanin (Fig. 3, lower left hand panel) is also consistent with the above spectroscopical observation (Fig. 2) of the presence of some residual methaemoglobin. Note also the small degree of HmuY-haem staining in the control incubation (minus pyocyanin) after 24 h, attributable to haemophore pickup of haem from the small amount of methaemoglobin formed through natural auto-oxidation over the period of the experiment. These findings strongly corroborated the above spectroscopic data showing that pyocyanin had facilitated formation of the ferrihaem-HmuY complex by augmenting production of the methaemoglobin species.

thumbnail
Fig 3. Native PAGE showing transfer of haem from oxyhaemoglobin to the HmuY haemophore during co-incubation with pyocyanin.

HmuY concentration was 16 μM, whilst haemoglobin was at 4 μM (with respect to tetramer), and pyocyanin at 100 μM. Buffer was 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5, and incubation was carried out at 37°C. Upper panel, gel stained with TMB-H2O2 to reveal the presence of haem. Lower panel, gel counterstained for protein with CBB after TMB-H2O2 staining. Hb, haemoglobin; haem-HmuY, ferrihaem-HmuY complex. Each track was loaded with 4 μg of haemoglobin.

https://doi.org/10.1371/journal.pone.0118319.g003

Neutrophil elastase breaks down methaemoglobin formed by the action of pyocyanin but not oxyhaemoglobin

A ubiquitous feature of lung infections, including those of CF patients, is the presence of neutrophil-derived proteases as a consequence of chronic and acute inflammation. Of these, neutrophil elastase has been shown to be the most abundant, reaching levels as high as 2 μM in the bronchoalveolar lavage fluids from CF patients with lung infections [31,32]. We therefore firstly examined the effect of neutrophil elastase on oxyhaemoglobin. Although the protease (at 2 μM) was able to mediate a small degree of haemoglobin oxidation during a 6-h incubation period (Soret band blue shift to 406 nm, plus decreases in A576 and A541, and increases in A500 and A630) (Fig. 4A), loss of Soret band intensity, which would be indicative of protein breakdown and haem release, was not seen. Using the decrease in A577 to determine the relative level of methaemoglobin formation, it was found after 6 h, that the rate of oxidation was lower than the control auto-oxidation (data not shown). Cosgrove et al. [32] recently found that neutrophil elastase and Pseudomonas elastase could break down haemoglobin. However, this is likely explained by the nature of the commercial substrate they used, which is known to contain a high proportion of the protein in the methaemoglobin form. To confirm this, we examined the ability of neutrophil elastase to break down methaemoglobin induced by treatment with sodium nitrite. As shown by the rapid decrease in Soret band intensity (Fig. 4B), 2 μM neutrophil elastase was effective in breaking down nitrite-induced methaemoglobin and releasing haem. This effect was also seen down to a protease concentration of 0.25 μM (data not shown). Under these conditions, the spectrum of the product formed by the action of the neutrophil elastase after 24 h had a 393 nm Soret band plus shoulder at 360 nm (data not shown), which is typical of free iron(III) protoporphyrin IX in the μ-oxo dimeric form [52,53]. The series of difference spectra produced by subtracting each neutrophil elastase-methaemoglobin spectrum from the control methaemoglobin spectrum at each incubation time period (Fig. 4B, inset graph) showed that the enzyme had progressively degraded the methaemoglobin substrate (405 nm Soret bands). These data contrast starkly with the inability of neutrophil elastase to bring about oxyhaemoglobin breakdown when the haem iron was in the Fe(II) oxidation state, even at the highest protease concentration examined.

thumbnail
Fig 4. Neutrophil elastase does not breakdown oxyhaemoglobin but degrades methaemoglobin.

Neutrophil elastase (2 μM) was incubated at 37°C with 4 μM oxyhaemoglobin (A) or with methaemoglobin (B), in 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5. The methaemoglobin substrate was formed by incubation of 100 μM oxyhaemoglobin with a 4-fold molar excess of sodium nitrite for 1 h at 37°C. Inset graph in panel A, difference spectra produced by subtraction of the elastase-methaemoglobin spectra from the control methaemoglobin spectra at each time point to show the amounts of methaemoglobin degraded with time (405 nm Soret band). Inset graph in panel B, difference spectra made by subtracting the enzyme incubation spectra from those of the control methaemoglobin spectra at each time period to show the incremental amounts of methaemoglobin degraded.

https://doi.org/10.1371/journal.pone.0118319.g004

Neutrophil elastase degradation of methaemoglobin formed by the action of pyocyanin

Given the susceptibility of nitrite-induced methaemoglobin, it follows that pyocyanin-mediated oxidation would also yield methaemoglobin susceptible to neutrophil elastase. Predictably, we found that the pyocyanin-induced methaemoglobin was also degraded as shown by the decrease in the Soret band absorbance (Fig. 5A). This was confirmed by examining the difference spectra as above for the NaNO2-induced methaemoglobin substrate (Fig. 5A, inset graph). However, the amount of methaemoglobin degraded was lower than that of the nitrite-induced methaemoglobin. Moreover, after 7-h incubation, addition of 10 mM sodium dithionite yielded a deoxyhaemoglobin spectrum, with no evidence of a haemoglobin haemochrome present (data not shown). To test if the lower susceptibility of pyocyanin-induced methaemoglobin was due to the presence of pyocyanin, we determined whether it could inhibit the elastase-catalysed hydrolysis of Azocoll and the synthetic substrate MeOSuc-Ala-Ala-Pro-Val-pNA. We found that at a physiologically relevant concentration (100 μM) [38] pyocyanin had no significant effect on neutrophil elastase activity (data not presented). However, we confirmed the susceptibility of the pyocyanin-induced methaemoglobin substrate to neutrophil elastase using non-reducing SDS-PAGE (Fig. 5B). Despite the apparent lower susceptibility of methaemoglobin formed by pyocyanin towards neutrophil elastase compared to that induced by nitrite (as shown by spectroscopy), we found that the protease brought about progressive reductions in CBB and TMB-H2O2 staining of the protein over a 24-h period (Fig. 5B, upper gels), indicating both protein breakdown and haem loss. In comparison, little neutrophil elastase degradative activity was seen against a sample of control haemoglobin auto-oxidised for 7 h (Fig. 5B, lower gels).

thumbnail
Fig 5. Spectroscopic (A) and SDS-PAGE (B) demonstration of the breakdown of pyocyanin-induced methaemoglobin by neutrophil elastase.

Methaemoglobin was formed from oxyhaemoglobin (100 μM with respect to tetramer) by incubation with 50 μM pyocyanin for 7 h. Total haemoglobin in the assay was 4 μM and neutrophil elastase was at 2 μM, and digestions were carried out at 37°C in 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5 at 37°C. SDS-PAGE was carried out under non-reducing conditions and gel tracks are loaded with 4 μg haemoglobin. Inset in panel A, difference spectra produced by subtracting the neutrophil elastase-methaemoglobin spectrum from the control methaemoglobin spectrum at each incubation time point to show the progressive breakdown of the methaemoglobin substrate. Panel B, pyocyanin-induced methaemoglobin plus neutrophil elastase (uppermost gels) and lower gels, control auto-oxidised methaemoglobin plus neutrophil elastase. Gels were firstly stained with TMB-H2O2 to reveal the presence of haem and then counterstained for protein with CBB.

https://doi.org/10.1371/journal.pone.0118319.g005

Synergistic activity of pyocyanin and K-gingipain in mediating haem release from oxyhaemoglobin and in HmuY-haem complex formation

Given the role of Kgp in haemoglobin breakdown and formation of the μ-oxo bishaem component of the pigment [22,23], and the fact that Kgp enhances the haem transfer from methaemoglobin to HmuY [28], it was appropriate to examine its ability to breakdown methaemoglobin formed via the action of pyocyanin. We observed that Kgp mediated a rapid breakdown of methaemoglobin as evidenced by the loss of Soret band absorbance (Fig. 6A). Since Kgp degraded pyocyanin-induced methaemoglobin, it follows that a similar synergistic effect should operate for HmuY haem binding from this substrate. Pyocyanin-induced methaemoglobin (4 μM with respect to tetramer) was incubated with 16 μM HmuY in the presence and absence of 1 μM Kgp. For both incubations we observed Soret band red shifts to 411 nm and changes in the visible bands with time, indicative of formation of the HmuY-haem complex. These visible band absorbance changes were more apparent when difference spectra were made by subtracting the time-zero sample from the subsequent spectra at each time point which revealed spectra with bands at 528 and 558 nm (Fig. 6B), which gradually grew in intensity. In contrast, the degree of HmuY-haem complex from pyocyanin-induced methaemoglobin was minimal in the absence of Kgp (Fig. 6C). To quantify the degree of HmuY-haem complex formation, the absorbance change between the peak at 560 nm and the trough at 580 nm was plotted against time (Fig. 6D). This showed a larger amount of HmuY-haem complex formation from pyocyanin-induced methaemoglobin in the presence of Kgp.

thumbnail
Fig 6. Kgp degrades pyocyanin-induced methaemoglobin and facilitates haem transfer to HmuY.

(A) Pyocyanin-induced methaemoglobin (4 μM with respect to tetramer) was incubated with 1 μM Kgp at 37°C in 0.14 M NaCl, 0.1 M Tis-HCl, pH 7.5, and the methaemoglobin Soret band intensity monitored with time. Visible spectral regions showing the formation of the HmuY-haem complex after incubation of pyocyanin-induced methaemoglobin with HmuY in the presence (B) and absence (C) of Kgp are shown. HmuY concentration was 16 μM, and incubation conditions as in (A). (D) Change with time of the absorbance between the Q band at 560 nm and the trough at 580 nm as a measure of the formation of HmuY-haem complex from pyocyanin-induced methaemoglobin in the presence and absence of Kgp.

https://doi.org/10.1371/journal.pone.0118319.g006

In contrast to neutrophil elastase, Pseudomonas elastase was relatively inefficient in degrading methaemoglobin formed by the action of pyocyanin as seen by the low degree of Soret band loss. From this we calculated that the Pseudomonas elastase degraded only 54% of the methaemoglobin compared to that mediated by neutrophil elastase over the same time period (7 h) under the same conditions as described in Fig. 5 (data not shown). It is noteworthy that Smith et al. [54] found that Pseudomonas elastase expression was down-regulated in strains derived from adult patients who were chronically infected with P. aeruginosa. Coupled with the above observations on Pseudomonas elastase, it is likely that early in establishment of infection, P. gingivalis may be reliant upon neutrophil elastase to engender an initial supply of free haem by degrading methaemoglobin before sufficient gingipain expression can take on the role of aiding haem acquisition through HmuY haemophore deployment.

Mouse lung infection model

In these experiments we evaluated the effect of pyocyanin, either alone or in combination with P. gingivalis, in the development of pulmonary infection in C57/BL/6 mice in line with the mono-infection model described by Nemec et al. [44]. Importantly, this avoided any complications which would arise from the pathogenic effects of using a co-infection with P. aeruginosa as a source of pyocyanin. Clinical symptoms of pneumonia and myeloperoxidase activity, as a measure of neutrophil activation in the lung tissue, were assessed. The course of P. gingivalis W83 infection with or without pyocyanin, in terms of mouse survival is illustrated in Fig. 7. Mice intra-tracheally inoculated with PBS or with PBS plus pyocyanin remained healthy throughout the observation period. However, 30% of mice inoculated with P. gingivalis alone, and 70% of mice inoculated with P. gingivalis plus pyocyanin died within 20 h after infection. These differences were statistically significant and were even more profound at longer times post-infection. While all animals infected with P. gingivalis in the presence of pyocyanin were dead by 48 h, no more casualties were observed in the group inoculated with P. gingivalis alone up to the end of the experiment (72 h).

thumbnail
Fig 7. Kaplan-Meier plots showing differences in survival of C57/BL/6 mice after intra-tracheal challenge with P. gingivalis, P. gingivalis plus pyocyanin, PBS, and PBS plus pyocyanin.

Mice (10 animals per group) were inoculated with 3×109 CFU of wild-type P. gingivalis W83 (Pg) or P. gingivalis plus 40 μg pyocyanin (Pg+PCN) into the lungs via the trachea. Control groups were challenged with PBS or with PBS plus 40 μg pyocyanin (PCN). The survival of mice was monitored during whole time of procedure. Log-rank test, n = 10 in all cases, **P<0.01 and ***P<0.001 for control PBS or PBS+PCN-inoculated, and P. gingivalis- or P. gingivalis+PCN-inoculated animals, respectively.

https://doi.org/10.1371/journal.pone.0118319.g007

Mice challenged either with P. gingivalis, or P. gingivalis plus pyocyanin demonstrated evidence of clinical infection characterized by respiratory failure, weight loss, ruffled fur, disruption to feeding, loss of activity, and ataxia/tremor (Fig. 8), signs that are associated with an ongoing infection. However, symptoms of pneumonia were significantly less developed in mice inoculated with P. gingivalis only. This was most clearly seen in the case of loss of activity and ataxia/tremor. The last symptom was barely observed in mice infected with P. gingivalis alone. Cumulatively these results clearly indicated that pyocyanin enhances virulence of P. gingivalis in the infected lungs.

thumbnail
Fig 8. Clinical evaluation scores of mice (on a scale of 0 to 3) after intra-tracheal inoculation with 3×109 CFU P. gingivalis W83, or 3×109 CFU P. gingivalis W83 + 40 μg pyocyanin.

Filled bars, mice challenged with P. gingivalis plus pyocyanin. Statistical significance: *P<0.01; **P<0.05; ***P<0.005.

https://doi.org/10.1371/journal.pone.0118319.g008

Assessment of viable organisms in the lungs of infected mice

The enhanced morbidity and mortality induced by P. gingivalis plus pyocyanin can be due to increased survival and/or proliferation of bacteria in the lungs. Therefore homogenates of lung collected at 16 h and 24 h post inoculation were plated and the CFU of P. gingivalis counted after anaerobic culture. Surprisingly there was no significant difference in the CFU count between the groups (Fig. 9). Collectively, these data show that the presence of pyocyanin when administered along with P. gingivalis did not affect colonization, survival and proliferation of bacteria in the lungs. Instead our results suggest that the enhanced pathogenicity of P. gingivalis in the presence of pyocyanin is due to increased secretion of virulence factor(s) rather than the improved fitness of bacteria per se in the infected lungs.

thumbnail
Fig 9. Viable cell counts (CFU) of P. gingivalis W83 in the lungs of mice challenged with bacteria in the presence and absence of pyocyanin.

Mouse lungs were homogenized in PBS and 10-fold serial dilutions plated onto horse blood agar and incubated anaerobically. NS, not statistically significant. Pg, P. gingivalis alone; Pg+PCN, P. gingivalis plus 40 μg pyocyanin.

https://doi.org/10.1371/journal.pone.0118319.g009

Myeloperoxidase activity as a measure of neutrophil activation

One of the well characterized effects of gingipain proteases on the host is enhancement of neutrophil attraction by increasing chemotactic activity of IL-8 [5557] and neutrophil activation via the PAR-2 pathway [58]. Excessive amounts of activated neutrophils in the tissues may have a deleterious effect on lung biology and explain the difference in mortality/morbidity between mice infected with P. gingivalis and those challenged with P. gingivalis in the presence of pyocyanin. To assess this we measured myeloperoxidase activity which is a marker of neutrophil activation and accumulation in tissues during inflammation as a result of infection [59]. This activity was assayed in the lung tissues from surviving mice in each experimental group of animals at 24, 48 and 72 h after inoculation. Protein extracts of the lung homogenates showed significantly higher myeloperoxidase levels in animals inoculated with P. gingivalis or with P. gingivalis plus pyocyanin, compared with mice inoculated with PBS or PBS plus pyocyanin only (Fig. 10). Importantly, however, compared with infection with P. gingivalis, inoculation with P. gingivalis plus pyocyanin was associated with the much higher myeloperoxidase activities and hence the greatest neutrophil influx into the lung. These myeloperoxidase levels were measured only at 24 h since at later times post-challenge no mice were alive which had been infected with P. gingivalis plus pyocyanin (Fig. 7). It is important to note here that neutrophil influx as a measure of inflammation correlated with significantly increased clinical evaluation scores and hence severity of infection.

thumbnail
Fig 10. Myeloperoxidase activities (MPO) in homogenates of mouse lungs challenged with P. gingivalis, P. gingivalis plus pyocyanin, or pyocyanin alone.

The MPO activity was expressed as % of control activity (mice inoculated with PBS only). The data points represent the mean ± SD from two independent MPO assays performed for each group (PBS+PCN, P. gingivalis, and P. gingivalis+PCN). The number of animals in the PBS and PBS+PCN groups was 10, while those in the P. gingivalis and P. gingivalis+PCN groups was 8 and 4 (at 24 h), 7 and 3 (at 48 h), and 7 and 0 (at 72 h), respectively. Statistical significance: ***P<0.005.

https://doi.org/10.1371/journal.pone.0118319.g010

Levels of methaemoglobin and total haem in mouse lung homogenates

Concentrations of both oxyhaemoglobin and methaemoglobin were measured spectrophotometrically in the lung homogenates which had been clarified by centrifugation. This enabled calculation of the relative percentages of oxy- and methaemoglobin species present. We found that the mean percentage of methaemoglobin in lung homogenates from control PBS-inoculated animals was 28.5 ± 5.3 (n = 11), but this was not statistically different from mice inoculated with PBS plus pyocyanin (31.1 ± 7.8; n = 13). However, there was a significant elevation (P = 0.014) in the percentage of methaemoglobin present in lung homogenates from mice challenged with P. gingivalis plus pyocyanin (37.1 ± 14.8; n = 15) compared to those challenged with P. gingivalis alone (24.7 ± 7.4; n = 19) (Fig. 11A).

thumbnail
Fig 11. Methaemoglobin and total haem levels in homogenates of mouse lung tissues 24 h after intra-tracheal challenge with P. gingivalis, P. gingivalis plus pyocyanin, or pyocyanin alone.

(A) Percentage methaemoglobin compared to that of oxyhaemoglobin in the soluble protein fraction of the lung homogenates. (B) Total haem levels in the homogenate fraction comprising the insoluble tissues and bacteria. Lungs were homogenised, diluted with PBS, clarified by centrifugation, and the UV-visible spectra of the supernatant fractions recorded immediately to determine the oxyhaemoglobin and methaemoglobin concentrations by multicomponent analysis from A576 and A630 values as previously described [12]. The methaemoglobin levels are expressed as a percentage of the total haemoglobin present (oxyhaemoglobin plus methaemoglobin). The pellets after the centrifugation step containing insoluble tissue and bacteria were solubilised in 0.1 M NaOH in a bath sonifier and assayed for total haem and protein. The haem data are expressed as nmol haem per mg protein. Experimental groups challenged with phosphate-buffered saline (PBS), pyocyanin (PCN), P. gingivalis only (Pg), and P. gingivalis plus pyocyanin (Pg+PCN). Kruskal-Wallis one-way analysis of variance, statistical significance: **P < 0.01; NS, not statistically significant.

https://doi.org/10.1371/journal.pone.0118319.g011

In addition, we assayed for total haem in the supernatant fractions from the lung homogenates and found that these correlated with the total haemoglobin concentrations, i.e. both methaemoglobin and oxyhaemoglobin combined (data not shown). As discussed above, methaemoglobin represents the primary substrate from which haem is acquired by P. gingivalis via the actions of Kgp and HmuY [22,23]. Given that pyocyanin, when administered along with P. gingivalis resulted in an elevation of the level of methaemoglobin in the soluble fraction from the lung homogenates (Fig. 11A), it may be anticipated that this would lead to an increase in haem acquisition by the bacterial cells which would be found pelleted along with the insoluble lung tissues (after centrifugation at 18,000×g for 20 min) rather than in the supernatant fraction. Therefore the total haem present in the homogenate pellets relative to the total protein was measured (Fig. 11B). We observed statistically significant differences between mice challenged with P. gingivalis plus pyocyanin and those challenged with P. gingivalis only (P = 0.0015). Thus, although pyocyanin instilled into mouse lungs alone did not itself increase the level of methaemoglobin, there was a significant increase in the amount of methaemoglobin as a percentage of the total haemoglobin in the lung homogenates when pyocyanin was administered alongside P. gingivalis. This is not surprising since the bacterial infection alone, which demonstrably lead to inflammation (as manifested by elevated levels of neutrophil myeloperoxidase), would lead to micro-bleeds and hence free haemoglobin. This, in turn, would be rapidly oxidised in the presence of pyocyanin and, in the methaemoglobin form, would be more easily utilised, i.e. via direct extraction of the ferrihaem by the HmuY haemophore and degraded by neutrophil elastase or by P. gingivalis Kgp as demonstrated above. We would thus conclude that although P. gingivalis itself is capable of causing infection, the presence of pyocyanin considerably augments haem availability by promoting formation of methaemoglobin from which haem can be released by the action of the Kgp gingipain.

Gingipain activity in mouse lung homogenates

Gingipains are the most important virulence factors directly or indirectly (e.g., involved in fimbriae assembly) in all aspects of P. gingivalis virulence. It is well documented that P. gingivalis grown in haem-excess conditions up-regulates gingipain activity [16,60,61], and in the context of increased levels of methaemoglobin and haem in mouse lungs challenged with P. gingivalis plus pyocyanin, we postulated that elevated haem concentrations during infection may influence gingipain protease expression. To experimentally verify this possibility we measured total Rgp activities in the homogenates of mouse lungs. Gingipain activity was at low baseline levels in control mice receiving either pyocyanin or PBS (Fig. 12). Remarkably, however, and compliant with our hypothesis, significantly higher R-gingipain activity was detected in the lungs of animals which had been challenged with P. gingivalis plus pyocyanin, compared to those inoculated with P. gingivalis only (Fig. 12).

thumbnail
Fig 12. Rgp activity in the homogenates of lung tissue.

Total Rgp activity was measured using BApNA as substrate. See text for details. Student's t-test with Welch’s correction, statistical significance: *** P<0.0001.

https://doi.org/10.1371/journal.pone.0118319.g012

Effect of pyocyanin on growth and gingipain protease activity of P. gingivalis in vitro

It was also observed that pyocyanin did not affect the growth of P. gingivalis in vitro when added to the bacterial cultures either at the beginning of incubation or during the lag phase of growth (Fig. 13A). In addition, pyocyanin had no effect on cell-associated or extracellular R-gingipain activity from the bacterial cultures at the early-, middle-, late-logarithmic, or stationary phases of growth (Fig. 13B and 13C).

thumbnail
Fig 13. Effect of pyocyanin on the growth (A) and on cell-associated (B) and extracellular (C) R-gingipain protease activity of P. gingivalis in batch culture.

(A) P. gingivalis strain W83 was grown in the absence and presence of pyocyanin which was added at the start or in the lag phase of growth. Growth was measured by OD600 on duplicate samples and the average of the two is shown. (B and C) P. gingivalis W83 was grown in the absence and presence of pyocyanin as in (A) and the cultures were sampled at various times and assayed for both cell-associated (B) and extracellular (C) R-gingipain activity using the substrate BApNA after the bacteria were pelleted by centrifugation. The protease assays on bacterial cells and extracellular supernatant fractions at each time period were performed on six replicate samples and data are shown as mean ± SD. Pg+PCN, P. gingivalis+pyocyanin at start of incubation; Pg+PCN@4 h, P. gingivalis + pyocyanin added 4 h after start of incubation; Pg, P. gingivalis minus pyocyanin.

https://doi.org/10.1371/journal.pone.0118319.g013

Growth of P. gingivalis in the vicinity of P. aeruginosa on solid media

We tested the ability of P. gingivalis to grow in the presence of the secreted products of P. aeruginosa on blood agar. Pyocyanin producing strains PAO1 and LES 431 were grown as a single large colony overnight at 37°C by which time blue colouration was seen as halos around each strain. P. gingivalis was then streaked radially a few mm from, but not touching, each P. aeruginosa colony, and the plates were incubated for 4 days anaerobically. We observed that P. gingivalis grew and pigmented normally in the vicinity of both strains (Fig. 14). This indicated that P. gingivalis was capable of growing in the presence of extracellular products secreted by P. aeruginosa.

thumbnail
Fig 14. Growth of P. gingivalis on blood agar in the presence of secreted products of P. aeruginosa.

Columbia horse blood agar was inoculated with pyocyanin producing P. aeruginosa strains PAO1 and LES 431, and after overnight growth at 37°C, P. gingivalis was was streaked radially close to but not touching the P. aeruginosa growth, and incubated for 4 days anaerobically.

https://doi.org/10.1371/journal.pone.0118319.g014

Discussion

From a physiological perspective it is thought that the highly viscous nature of sputum, which limits gaseous diffusion, plus the metabolic activities of aerobic and facultative anaerobic species and neutrophils, which further deplete the oxygen levels, create micro-environments which are conducive to the growth of anaerobic bacteria in the infected lung, mostly in patients with CF [62,63]. However, the fact that oral BPAs with their obligate requirement for haem are found in the infected lung de facto indicates that sufficient haem must be available to support their growth. The richest sources of haem in the infected lung are erythrocytes released from micro-bleeds due to inflammatory damage to the delicate epithelium. Importantly, P. aeruginosa produces potent haemolysins capable of releasing haemoglobin from erythrocytes [20,21], and proteomic studies have identified haemoglobin-derived peptide fragments in CF sputum indicating that haemoglobin is indeed actively degraded in this environment [64]. Whilst haemoglobin levels have not been quantified in the CF lung, micro-bleeds into the airways could locally elevate haem levels to around 8 mM (i.e., the concentration of haem present as haemoglobin in whole blood should all the haem be liberated from the protein). This represents a sufficiency of haem which could enhance the virulence of P. gingivalis [15]. In addition, in keeping with their obligate haem requirements, both P. gingivalis and P. intermedia are also able to release haemoglobin from erythrocytes via expression of haemolysins and other proteases [6568].

For BPAs the key to utilisation of haemoglobin as a haem source lies in their ability to mediate haemoglobin haem-iron oxidation [1719]. Normally, upon release from haemolysed erythrocytes the haem iron of oxyhaemoglobin undergoes a small degree of auto-oxidation to the methaemoglobin form (HbFe+O2). This is a result of loss of intra-erythrocyte glutathione and methaemoglobin reductases, which reinstate its functionality as an oxygen carrier by re-reducing the haem iron to the Fe(II) state, and through the effect of dilution which results in haemoglobin dissociation into αβ dimers, which display increased oxidation compared to the intact tetrameric protein [69]. However, in neutral to alkaline pH environments (as may be encountered in the diseased periodontal pocket and the lung) the natural auto-oxidation rates of haems in the oxyhaemoglobin tetramer and αβ dimers are at their lowest [70]. Thus, to satisfy haem requirements and to reach high numbers in the CF lung [7,8], BPAs must be reliant upon a mechanism, which would ensure effective haemoglobin oxidation. The production of pyocyanin by P. aeruginosa appears to be a phenotype common to CF isolates [71]. Relative to clinical non-epidemic and environmental strains, cultures of pyocyanin over-producing clinical isolates (such as P. aeruginosa LES), have been shown to generate pyocyanin levels as high as 40 μM in vitro [39]. Pyocyanin is abundant in the sputa of CF and bronchiectasis patients whose lungs are infected with P. aeruginosa, where average concentrations of around 80 μM have been observed [38]. The central role played by pyocyanin in pathogenicity is demonstrated by the fact that pyocyanin-deficient mutant strains of P. aeruginosa display attenuated virulence in acute and chronic mouse lung infection models [33]. Besides perturbing host cellular functions [34], including damage to lung epithelial cells [72], pyocyanin and other phenazine compounds also act as antibiotics [73]; these effects being linked to the generation of superoxide and hydrogen peroxide [74,75]. However, P. gingivalis is resistant to reactive oxygen species-dependent antimicrobial activity of the host [76]. In keeping with this, we found that growth and gingipain production by P. gingivalis in liquid culture was unaffected by the presence of pyocyanin (Fig. 13). Moreover, we observed that it can also grow and pigment when cultured on blood agar in the vicinity of pyocyanin producing P. aeruginosa strains PAO1 and LES 431 (Fig. 14). It is also noteworthy that formation of the μ-oxo dimeric haem-containing pigment by P. gingivalis from Fe(II) haems (liberated from haemoglobin) would tie up superoxide [19]. In addition, both the μ-oxo dimer and the haematin monomer (Fe(III)PPIX.OH), which comprises 10–15% of the P. gingivalis pigment [19], and is the main component of the P. intermedia pigment [18], also possess intrinsic catalase activity which would destroy H2O2 [77]. Whilst superoxide is also potentially harmful to the bacterium, it is noteworthy that P. gingivalis has an intracellular superoxide dismutase [78,79] to cope with fluxes of this oxidant. In addition, in the lung it is likely that the cell-surface haem pigments of these two species would also offer a degree of protection through the ability of the ferrihaems to oxidatively inactivate pyocyanin in the presence of H2O2 [80].

In this study we showed that pyocyanin induced rapid haemoglobin oxidation over a range of concentrations found in the sputum of CF patients. For example, 100 μM pyocyanin induced an oxidation rate 40-fold that of the natural auto-oxidation, whilst the lowest concentration tested (5 μM) mediated a 5-fold increase compared to auto-oxidation. This is notable since the average level of pyocyanin production in cultures of clinical non-epidemic, non-pyocyanin over-producers and environmental isolates of P. aeruginosa, is around 4 μM [39]. It is therefore likely that any free oxyhaemoglobin entering the lung would become unavoidably oxidised in the presence of pyocyanin and would represent a ready pool of methaemoglobin for breakdown and haem release. In this respect, after 24 h there was a statistically significant elevation in the percentage of methaemoglobin in lung homogenates from mice given P. gingivalis plus pyocyanin compared to lungs of mice challenged with P. gingivalis only. We speculate that the presence of pyocyanin, through augmenting the natural (auto-oxidation) levels of methaemoglobin, is a means by which haem availability may be increased sufficiently to establish infection and/or to enhance the virulence of other haem-requiring species.

Here we have demonstrated that pyocyanin facilitates extraction of haem from haemoglobin by the P. gingivalis HmuY haemophore by rapidly oxidising oxyhaemoglobin to methaemoglobin. These findings would suggest that oxyhaemoglobin “primed” by reaction with pyocyanin is a ready and facile substrate which P. gingivalis may utilise to gain haem when entering the infected lung, and place these bacteria at an advantage during their early colonisation of this environment. However, in the absence of sufficient bacterial protease activity (as may be the case during the early stages of infection) it is likely that neutrophil elastase, which is abundant in the CF lung during infection [31,32], serves the role of degrading methaemoglobin for subsequent haem capture via bacterial haemophores. We note that instillation of pyocyanin into the lung can result in pathological changes [37], and here we showed that pyocyanin itself promoted a small degree of inflammatory neutrophil infiltration into the lung tissue as measured by raised lung homogenate myeloperoxidase activities, confirming the observations from other studies [33]. Importantly, however, we also found that myeloperoxidase activity was significantly increased in the presence of both P. gingivalis and pyocyanin, compared to that in lungs from mice challenged only with PBS, PBS plus pyocyanin, or with P. gingivalis only. Taken together, our findings also point to the likelihood that neutrophils play a significant, yet inadvertent, part in the haem acquisition process by invading bacteria, especially during co-colonisation with pyocyanin-producing P. aeruginosa strains. In addition, the combination of neutrophil elastase and pyocyanin may be a crucial factor for BPAs in haem procurement at stage before they can liberate sufficient haem through their own acquisition systems. In contrast, however, we found that elastase from P. aeruginosa was inefficient in degrading methaemoglobin formed by the action of pyocyanin compared to K-gingipain, which may advantage P. gingivalis in the competition for haem.

In this study we employed a mouse model to evaluate in isolation the effects of pyocyanin on mono-infection of the lung with P. gingivalis. This avoided any compounding pathological complications, which would arise from the presence of P. aeruginosa as a source of pyocyanin in a co-infection. Interestingly, the numbers of viable P. gingivalis cells in mouse lungs after inoculation of P. gingivalis or P. gingivalis plus pyocyanin were similar, indicating that the increased mortality of mice in the presence of both P. gingivalis and pyocyanin may not have been due to any increase in bacterial load but due to an increase in virulence properties. Indeed, we observed that R-gingipain activity was statistically significantly elevated in the lungs of mice challenged with both P. gingivalis plus pyocyanin compared to those receiving only P. gingivalis. It is known that growth of P. gingivalis under haem excess enhances virulence in mouse pathogenicity models [15], and that this increased pathogenicity correlates with increased cellular R-gingipain activity [16,60,61]. Minas et al. [81] have shown that growth of P. gingivalis in the chemostat with haemoglobin as substrate induces high levels of R-gingipain activity. They also have shown that although haem availability brings about increased biomass, it also induces greater total R-gingipain activity at concentrations beyond which it ceases to exert a growth rate enhancing effect [82]. These effects may explain the observations of similar bacterial numbers but the increased R-gingipain levels in the lungs of mice challenged with P. gingivalis plus pyocyanin compared to those with P. gingivalis alone. Thus, the excess of free haem in the lungs of mice co-inoculated with P. gingivalis and pyocyanin would stimulate gingipain expression which in turn would enhance neutrophil influx and activation, contributing to increased severity of infection. Moreover, we also found that pyocyanin had no effect on the growth of P. gingivalis in vitro when added to the bacteria either at the start of the incubation or during the lag phase of growth. Pyocyanin also had no inhibitory effect on either cell-associated or extracellular R-gingipain activity throughout the growth cycle. These data demonstrate that the presence of pyocyanin in the lung may not abrogate the activity of one of the major virulence factors of this organism, i.e., gingipain proteases.

The ecological inter-relationships between anaerobes, including the haem-requiring BPAs and P. aeruginosa in the infected lung is not clear. However, it is known that P. aeruginosa also has a metabolic requirement for haem and iron [83,84], which the organism would need to establish an infection in an environment where the haem availability may otherwise be restricted by the host via sequestration by serum albumin and haemopexin. In the context of haem and aerobiosis, Diaz and Rogers [85] have shown that P. gingivalis can grow not only under strictly anaerobic conditions, but also in the presence of 6% v/v O2. This ability to survive in O2 is linked to expression of NADH oxidase, NADH peroxidase and superoxide dismutase (SOD) [85] and the importance of this anti-oxidant system is highlighted by the observation that SOD-negative mutants of P. gingivalis do not survive exposure to oxygen [86]. It is also significant to note that P. gingivalis can tolerate up to 10% oxygen in the presence of haem [85]. These physiological adaptations would permit P. gingivalis to co-exist in the micro-aerobic conditions (as in the CF lung), which P. aeruginosa can also tolerate [12,8789].

It is generally accepted that micro-aerobic conditions prevail in the CF lung as a result of oxygen depletion due to the metabolism of aerobic bacteria and to the presence of the viscous mucus secretions which limit gas exchange and oxygenation. In this context it is important to note that Minetti et al. [42] demonstrated that haemoglobin oxidation by phenazine is actually increased at reduced O2 levels, and so pyocyanin-mediated methaemoglobin formation could proceed in the CF lung where there may be both full oxygenation and also in local microenvironments where other co-colonising species and P. aeruginosa [63] may induce micro-aerobic conditions. It is also noteworthy that in the Drosophila model of polymicrobial infection with other bacterial species of oropharyngeal origin can increase gene expression of a number of P. aeruginosa virulence-related genes including phzA1, which encodes for a protein involved in phenazine biosynthesis [90].

The mechanisms through which haem becomes available during lung infections have not been previously investigated in great detail. However, results presented here have revealed that pyocyanin rapidly oxidises oxyhaemoglobin to methaemoglobin and that this is a facile substrate for the P. gingivalis Kgp and the HmuY haemophore, which can extract haem from it. The presence of pyocyanin also augmented the breakdown of oxyhaemoglobin and release of haem by neutrophil elastase, which is considered to be most abundant host protease present in the CF lung during bacterial infection [30,31]. Thus, our above observations are of significance as they indicate that free haem levels may also be elevated inadvertantly by the host in response to infection by P. aeruginosa.

Data published by others, along with our results presented here demonstrate that cooperation exists between the respiratory pathogens and certain oral bacteria, such as P. gingivalis, thus enhancing their virulence. For example, it has been found that P. gingivalis may increase invasion into, and transiently suppress P. aeruginosa-induced apoptosis of respiratory epithelial cells, which may facilitate intracellular pathogen proliferation and dissemination of infection [91,92]. In addition, mixed invasion with both of these bacterial species triggers more epithelial cell death. Whilst this may be advantageous to the host in that it may contribute to elimination of infected cells, it also causes tissue destruction. Several studies also support the importance of encapsulated anaerobic bacteria in respiratory infections [93]. Moreover, when relatively non-encapsulated isolates of Porphyromonas strains were mixed with P. aeruginosa, enhanced virulence of the latter was observed. Confirming our hypothesis of synergy between P. aeruginosa and P. gingivalis, it has been also very recently demonstrated that the relative loads of P. gingivalis compared to P. aeruginosa were higher in tracheal aspirate samples than in the corresponding periodontal pocket samples [5].

In summary, although pyocyanin per se, is known to bring about pathological changes in the lungs of experimental animals when administered repeatedly in high doses [37], we have demonstrated for the first time that it has a significant effect on haem availability by increasing the level of methaemoglobin in the lung during pulmonary challenge with P. gingivalis. In addition, the presence of pyocyanin results in increased expression of R-gingipain protease activity, a major P. gingivalis virulence factor. Our findings also show that the paradigm of haem acquisition displayed by the BPAs may extend to co-infections of these bacteria with P. aeruginosa and offer a biochemical mechanism for the ability of BPAs to obtain sufficient haem in the infected lung. An increased abundance of iron protoporphyrin IX may also enable BPAs to endure the micro-aerobic environment and to contribute to the growth and virulence of other haem-requiring bacterial species and thus help to shape the microbiological profile in the infected lung. Our study demonstrates that anaerobic pathogens, such as P. gingivalis, are worthy of further study in the context of a variety of pulmonary infections, including those of the CF lung, as well as in the context of their wider role of the lung microbiome. Because knowledge regarding the association of anaerobic bacteria with lung diseases, and whether or how they should be treated is limited, our study provides new data which should be treated as the basis for future clinical experiments. It is thus likely that chemotherapeutic methods which restrict availability of virulence regulatory factors, such as haem, may need to be developed for treating lung infections, mostly recurring lung infections in CF patients.

Materials and Methods

Isolation and purification of HmuY

P. gingivalis apoHmuY lacking the first 25 residues (NCBI accession number CAM 31898) was expressed using a pHmuY11 plasmid and Escherichia coli ER2566 cells (New England Biolabs) and purified from a soluble fraction of the E. coli cell lysate as described previously [25]. As the soluble protein released from the cell membrane, the purified HmuY lacked the signal peptide and first five amino acid residues (CGKKK) of the nascent secreted protein [25,27].

Haemoglobin preparations

Oxyhaemoglobin for use in oxidation rate measurements and protease degradation experiments was prepared from fresh horse erythrocytes as described previously [53] and stored at -80°C in 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5 until required. Methaemoglobin was formed by incubation of 100 μM oxyhaemoglobin with a 4-fold molar excess of NaNO2 for 1 h at 37°C [22,23] or with P. aeruginosa pyocyanin (Sigma-Aldrich; P0046) at concentrations between 5 and 100 μM in 0.14 M NaCl, 0.1 M Tris-HCl, pH 7.5.

Rates of oxyhaemoglobin oxidation

The rates of oxyhaemoglobin (HbO2) oxidation were also followed quantitatively using plots of log([HbO2]t/[HbO2]t0) against time t, where the ratio of HbO2 concentration after time t to that at time zero (t0) was monitored by the absorbance changes of the α band (576 nm) of oxyhaemoglobin [24,46]. The relative rates of oxidation were calculated by linear regression using GraphPad Prism.

Determination of the concentration of methaemoglobin

The concentrations of methaemoglobin in oxyhaemoglobin preparations were calculated according to the method of Winterbourne et al. [45] using the A576 and A630 values as described previously [22].

Assay for total haem and protein in lung tissues

Parallel aliquots of lung homogenates were centrifuged as above to pellet insoluble tissue residues plus the biomass (in the case of the infected samples). Portions of this were solubilised in 0.1 M NaOH for 15 min in a sonication bath. The samples were then centrifuged at 18,000×g for 5 min and any lipid floating on the top of the supernatant carefully removed. The soluble fraction thus obtained was then assayed for total protein assay using the bicinchoninic acid (BCA) method, and for haem using the method of Pandey et al. [94]. The assays were calibrated against haemin chloride (Sigma-Aldrich) and bovine serum albumin.

UV-visible spectroscopy

UV-visible spectra were recorded with a Ultrospec 2000 spectrophotometer (Biochrom Ltd) using 1-cm pathlength cuvettes.

Human neutrophil elastase

Neutrophil elastase (BioCentrum Ltd., Krakow, Poland; E-001) had a specific activity of 20.8 U/mg against the synthetic substrate N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide (MeOSuc-Ala-Ala-Pro-Val-pNA). Determination of the potential inhibitory effect of pyocyanin towards elastase (25 nM) was carried out using 250 μM MeOSuc-Ala-Ala-Pro-Val-pNA (SigmaAldrich; M6475) and Azocoll (Calbiochem; final concentration 7.5 mg/ml) in 0.14 M NaCl, 0.05 M Tris-HCl, 5 mM EDTA and 0.05% Tween-20, pH 7.5 at 37°C.

K-gingipain (Kgp) purification

Kgp was purified from the culture medium of P. gingivalis strain HG66 as described previously using gel filtration and arginine–Sepharose chromatography [95].

Pseudomonas elastase

Pseudomonas elastase was purchased from Calbiochem (product number 324676)

Polyacrylamide gel electrophoresis (PAGE)

PAGE in the presence of SDS was carried out using the buffer system of Laemmli [96]. To demonstrate haemoglobin proteolysis, samples were solubilised in application buffer for 1 h at 37°C without dithiothreitol. Where appropriate for native PAGE, urea and SDS were omitted from the separating gel, and the samples were also solubilised for 1 h at 37°C in application buffer but without SDS, urea and dithiothreitol. The gels were firstly stained for the presence of haem using tetramethylbenzidine/H2O2 (TMB-H2O2), and then counter-stained with Coomassie Brilliant Blue R-250 (CBB) to visualise the protein as previously described [28].

Bacterial strains and cultures

P. gingivalis strains W83 and W50 were used in this study. Bacteria were grown under anaerobic conditions (90% N2, 5% CO2, 5% H2) on blood (5% v/v sheep blood) agar plates or in liquid Schaedler broth (BTL, Lodz, Poland) supplemented with haemin (5 μg/ml; SigmaAldrich), L-cysteine (50 μg/ml; SigmaAldrich), menadione (0.5 μg/ml; SigmaAldrich). Bacteria from an overnight culture were centrifuged and the bacterial pellet was washed three times with phosphate–buffered saline (0.14 M NaCl, 0.0026 M KCl, 0.01 M Na2HPO4, 0.002 M KH2PO4), pH 7.4 (PBS), and re-suspended in PBS. Bacterial cell counts were standardized to an optical density of 1.0 at 600 nm (corresponding to 1×109 CFU ml-1).

Experimental animals

Specific pathogen-free (SPF) female C57/BL/6 mice, 10–12 weeks of age, were purchased from Harlan Laboratories (Udine, Italy). Mice were housed in positively-ventilated micro-isolator cages, were fed a standard laboratory diet, located in a room with laminar, high efficiency particle accumulation-filtered air within the animal care facility at the Jagiellonian University (Krakow, Poland). Control and bacterially-infected mice were housed in separate cages.

Ethical approval

All animal studies were performed in accordance with the protocols laid down by the Institutional Animal Care and Use I Regional Ethics Committee on Animal Experimentation, Krakow, Poland. This specific animal study was approved by the above ethics committee (Decision No. 94/2009).

Lung infection model in C57/BL/6 mice

The mouse lung infection model of Nemec et al. [44] was followed, employing an infectious dose of P. gingivalis of 3×109 CFU. In these experiments we evaluated the effect of only one variable (i.e., pyocyanin) on the virulence of P. gingivalis in the absence of P. aeruginosa, which would otherwise introduce other confounding pathological variables. For this we used an intra-tracheal challenge of 40 μg pyocyanin, a dose in line with that used in the study of Reszka et al. [80]. Mice were exposed to pyocyanin and/or to viable P. gingivalis W83 cells according to the following experimental protocols. To minimize any pain or distress during these experimental procedures, the C57/BL/6 mice were firstly anesthetized by intraperitoneal injection of ketamine (22 mg/kg; VetaKetam, Vet-Agro, Poland), and xylazine (2 mg/kg; Sedasin, Biowet) and ointment (Puralube Vet; Pharmaderm) applied to the eyes to prevent them from drying. The lungs of the animals were then challenged non-surgically by intra-tracheal administration of inocula (50 μl) containing 3×109 CFU of viable P. gingivalis W83 cells with or without 40 μg of pyocyanin (PCN; Sigma-Aldrich) in PBS. To minimize any damage to the airways, this was done using a blunt-ended 21-gauge silicone cannula needle which was applied to the back of the tongue above the tracheal opening. The animals were then maintained head upper most at a 45° angle until fully recovered from the anesthesia. Successful delivery of the PBS or bacteria with or without pyocyanin to the lungs was manifested in a choking reflex by the mouse immediately after instillation, followed by rapid breathing. Control mice were inoculated with 50 μl PBS or 50 μl PBS containing 40 μg pyocyanin. Three separate sets of in vivo experiments were conducted employing groups of 10 mice. All experimental procedures are summarized in Fig. 15.

thumbnail
Fig 15. Flow diagram of the experimental design and sampling protocol for the mouse lung infection model.

https://doi.org/10.1371/journal.pone.0118319.g015

CFU assay

On days 1, 2 and 3, mice were sacrificed by cervical dislocation and the lungs were immediately removed from the animals, weighed for purposes of standardization of the CFU and myeloperoxidase assays, homogenized in 1 ml of PBS using TissueLyser (Qiagen), and the homogenates 10-fold serially diluted. All samples (100 μl each) were plated on blood agar plates and cultured anaerobically for 7 days at 37°C, after which time visible colonies of P. gingivalis were counted to obtain the total viable cell numbers.

Determination of haemoglobin concentrations in mouse lung homogenates

Mouse lung homogenates as prepared above (0.3 ml) were diluted with 0.7 ml PBS, pH 7.4, and then centrifuged at 18,000×g for 20 min to pellet tissue residues. The clear supernatant fractions thus formed were carefully removed and UV-visible spectra recorded in 1-cm path length cuvettes. After subtraction of the buffer background, the absorbance values at 576 and 630 nm were used to calculate the concentrations of both oxyhaemoglobin and methaemoglobin by multicomponent analysis using the equations described previously [22].

Clinical evaluation scores

Scoring was made according to the clinical responses of C57/BL/6 mice to intra-tracheal inoculation with P. gingivalis W83 or P. gingivalis plus pyocyanin, and with PBS, or PBS plus pyocyanin. The clinical status of the mice was assessed during three days after challenge and included visual examination for mortality, respiratory failure, loss of body weight, feeding disruption, ruffled fur, loss of activity, ataxia and tremor. The clinical score from 0 to 3 was based on degree of physical symptoms (0, no sign; 1, mild; 2, moderate; 3, severe). All animals were monitored hourly over the experimental period. Any animals displaying severe or chronic pain or distress, e.g., immediate inactivity, breathing troubles and/or bleeding from the nose and mouth after inoculation of bacteria, pyocyanin or PBS were humanely euthanized. This was done by firstly anaesthetizing the animals as above by intraperitoneal injection with ketamine (22mg/kg) and xylazine (2mg/kg), followed by cervical dislocation.

Myeloperoxidase assay

Neutrophil influx into the lung tissue was analyzed by assaying for the enzymatic activity of myeloperoxidase, a marker for neutrophil accumulation [59]. Briefly, the lung tissues were weighed and homogenized in PBS, pH 7.4, containing 5 mg/ml hexadecyltrimethylammonium bromide, to produce 0.05% v/v homogenates. The homogenates were centrifuged at 40,000×g for 15 min and 10 μl of the supernatants were mixed with 240 μl dianisidine reagent comprising 16.7 mg dianisidine, 90 ml of distilled water, 10 ml PBS, and 50 μl of 0.29 M hydrogen peroxide. The reaction mixture was incubated for 5 min at room temperature, terminated by addition of 50 μl 2 M H2SO4, and then three absorbance readings at 30-s intervals were made using a micro-titre plate scanner at 450 nm as direct measure of myeloperoxidase activity. The activities in all samples were expressed as % of controls (lung homogenates from animals inoculated with PBS only).

Gingipain expression in lung tissues

Homogenates of the lung tissues were prepared as described above. In order to measure gingipain proteolytic activity, 5 μl of tissue homogenate were added to 95 μl of test buffer (100 mM Tris pH 7.5, 200 mM Gly-Gly, 5 mM CaCl2, 20 μg/ml aprotinin, 100 μg/mL PEFABLOCK) and supplemented with 10 mM L-cysteine in a 96-well microtitre plate. After 5-min pre-incubation at 37°C, the gingipain substrate benzoyl-arginine-p-nitroanilide (BApNA; SigmaAldrich) was added to give a working concentration of 200 μM. The protease activity was followed by measuring the release of p-nitroaniline by determination of absorbance at 405 nm using a microplate reader (SpectraMax Gemini, Molecular Devices) as described previously [97].

Effect of pyocyanin on the P.gingivalis growth in vitro

P.gingivalis strain W83 was grown in liquid Shaedler broth (BTL, Lodz, Poland) supplemented with haemin chloride (5 μg/mL; SigmaAldrich; product number H9039), L-cysteine (50 μg/mL; SigmaAldrich) and menadione (0.5 μg/mL; SigmaAldrich) under anaerobic conditions (90% N2, 5% CO2, and 5% H2). The influence of pyocyanin on the growth of P. gingivalis growth was examined by the adding pyocyanin (40 μg ml-1) to the bacterial cultures (3×109 cfu ml-1) either at the start of the incubation or 4 h after inoculation to test the effect in the early growth phase. The bacterial growth was monitored by measuring the OD600. Pyocyanin was omitted in the controls. The assays were done in duplicate.

Effect of pyocyanin on bacterial R-gingipain in vitro

P. gingivalis strain W83 (3×109 cfu ml-1) was grown as above in the absence and presence of pyocyanin (40 μg/ml) and the cultures were sampled at the start and at 6, 12, 18, 38 h post-inoculation and the cell-associated and extracellular gingipain activity assayed using BApNA as above after centrifugation of the cultures at 18,000×g for 15 min. The protease assays at each time period were performed on six replicate samples.

Growth of P. gingivalis in the presence of secreted products of P. aeruginosa

P. aeruginosa strains PAO1 and LES 431 were grown overnight at 37°C as single large colonies on Columbia horse blood agar plates, after which time pyocyanin was observed as a halo around the growth. P. gingivalis W50 was maintained anaerobically on horse blood agar and then streaked radially at a short distance from, but not touching, the P. aerugnosa colonies and the plates incubated anaerobically for 4 days. Pyocyanin producing P. aeruginosa strains PAO1 and LES 431 were kindly provided by Professor Craig Winstanley, Institute of Infection and Global health, the University of Liverpool.

Statistical analysis

All the data were reported as mean ± SD. To determine the significance of the results obtained from the in vivo experiments, comparisons between groups were made using the Mann-Whitney U test. Two-way ANOVA was employed for comparison of multiple groups. Results for the haem and methaemoglobin contents in mouse lungs were analyzed using Kruskal-Wallis one-way analysis of variance. The statistical significance of the gingipain protease expression data was tested using the Student's t-test with Welch’s correction. Differences between the numbers of viable P. gingivalis cells were analysed using Student's t-tests with equal (bacterial number after 16 h) or unequal (bacterial number after 24 h) variances. Values of P ≤ 0.05 were considered to be statistically significant.

Acknowledgments

Aneta Sroka and Karina Adamowicz are acknowledged for maintaining and cultivating P. gingivalis strains and helping with the animal studies, respectively.

Author Contributions

Conceived and designed the experiments: JWS JP TO. Performed the experiments: JWS DPB TO MO MB IG. Analyzed the data: JWS JP TO MO. Contributed reagents/materials/analysis tools: JWS JP TO. Wrote the paper: JWS MB MO JP TO.

References

  1. 1. Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull. 2002;61: 81–96. pmid:11997300
  2. 2. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infection. Am J Respir Crit Care Med. 2011;183: 1674–1679. pmid:21297072
  3. 3. van der Gast CJ, Walker AW, Stressmann FA, Rogers GB, Scott P, Daniels TW, et al. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J. 2011; 5: 780–791. pmid:21151003
  4. 4. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, et al. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One. 2013;8(4): e62917. pmid:23646159
  5. 5. Tan L, Wang H, Li C, Pan Y. 16S rDBA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary diseases. J Periodontal Res. 2014;49: 760–769. pmid:24484531
  6. 6. Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013;187: 1118–1126. pmid:23348972
  7. 7. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD, et al. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol. 2004;42: 5176–5183. pmid:15528712
  8. 8. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med. 2008;177: 995–1001. pmid:18263800
  9. 9. Ulrich M, Beer I, Braitmaier P, Dierkes M, Kummer F, Krismer B, et al. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis. Thorax. 2010;65: 978–984. pmid:20880875
  10. 10. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One. 2008;6;3(8): e2908. pmid:18682840
  11. 11. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA. 2007;104: 20529–20533. pmid:18077362
  12. 12. Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect. 2009;15: 454–460. pmid:19196263
  13. 13. Graves DT, Jiang Y, Genco CA. Periodontal disease: bacterial virulence factors, host response and impact on systemic health. Curr Opin Infect Dis. 2000;13: 227–232. pmid:11964791
  14. 14. Finegold SM, Strong CA, McTeague M, Marina M. The importance of black-pigmented gram-negative anaerobes in human infections. FEMS Immunol Med Microbiol. 1993;6: 77–82. pmid:8518764
  15. 15. McKee AS, McDermid AS, Baskerville A, Dowsett AB, Ellwood DC, Marsh PD. Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect Immun. 1986;52: 349–355. pmid:3699884
  16. 16. Marsh PD, McDermid AS, McKee AS, Baskerville A. The effect of growth rate and haemin on the virulence and proteolytic activity of Porphyromonas gingivalis W50. Microbiology. 1994;140: 861–865. pmid:8012602
  17. 17. Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci. 2003;4: 397–407. pmid:14683426
  18. 18. Smalley JW, Silver J, Birss AJ, Withnall R, Titler PJ. The haem pigment of the oral anaerobes Prevotella nigrescens and Prevotella intermedia is composed of iron(III) protoporphyrin IX in the monomeric form. Microbiology. 2003;149: 1711–1718. pmid:12855722
  19. 19. Smalley JW, Silver J, Marsh PJ, Birss AJ. The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the μ-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. Biochem J. 1998;331: 681–685. pmid:9560292
  20. 20. Vasil M L, Berka RM, Gray GL, Nakai H. Cloning of a phosphate-regulated hemolysin gene (phospholipase C) from Pseudomonas aeruginosa. J Bacteriol. 1982;152: 431–440. pmid:6811559
  21. 21. Fujita K, Akino T, Yoshioka H. Characteristics of heat-stable extracellular hemolysin from Pseudomonas aeruginosa. Infect Immun. 1988;56: 1385–1387. pmid:3128485
  22. 22. Smalley JW, Birss AJ, Szmigielski B, Potempa J. Sequential action of R and K-specific gingipains of Porphyromonas gingivalis in the generation of the haem-containing pigment from oxyhaemoglobin. Arch Biochem Biophys. 2007;465: 44–49. pmid:17577572
  23. 23. Smalley JW, Birss AJ, Szmigielski B, Potempa J. Mechanism of methaemoglobin breakdown by the lysine-specific gingipain of the periodontal pathogen Porphyromonas gingivalis. Biol Chem. 2008;389: 1235–1238. pmid:18713010
  24. 24. Byrne DP, Wawrzonek K, Jaworska A, Birss AJ, Potempa J, Smalley JW. Role of the cysteine protease interpain A of Prevotella intermedia in breakdown and release of haem from haemoglobin. Biochem J. 2009;425: 257–264. pmid:19814715
  25. 25. Olczak T, Sroka A, Potempa J, Olczak M. Porphyromonas gingivalis HmuY and HmuR: further characterization of a novel mechanism of heme utilization. Arch Microbiol. 2008;183: 197–210.
  26. 26. Wójtowicz H, Wojaczyński J, Olczak M, Króliczewski J, Latos-Grażyński L, Olczak T. Heme environment in HmuY, the heme-binding protein of Porphyromonas gingivalis. Biochem Biophys Res Commun. 2009;383: 178–182. pmid:19345198
  27. 27. Wójtowicz H, Guevara T, Tallant C, Olczak M, Sroka A, Potempa J, et al. Unique structure and stability of HmuY, a novel heme-binding protein of Porphyromonas gingivalis. PLoS Pathog. 2009;5(5): e1000419. pmid:19424422
  28. 28. Smalley JW, Byrne DP, Birss AJ, Wójtowicz H, Sroka A, Potempa J, et al. HmuY haemophore and gingipain proteases constitute a unique synthrophic system of haem acquisition by Porphyromonas gingivalis. PLoS One. 2011;6(2): e17182. pmid:21390208
  29. 29. Byrne DP, Potempa J, Olczak T, Smalley JW. Evidence of mutualism between two periodontal pathogens: co-operative haem acquisition by the HmuY haemophore of Porphyromonas gingivalis and the cysteine protease interpain A (InpA) of Prevotella intermedia. Mol Oral Microbiol. 2013;28: 219–229. pmid:23336115
  30. 30. Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol. 2008;40: 1238–1245. pmid:18395488
  31. 31. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutièrrez JP, Hull J, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 1997;156: 197–204.
  32. 32. Cosgrove S, Chotirmall SH, Greene CM, McElvaney NG. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J Biol Chem. 2011;286: 7692–7704. pmid:21193404
  33. 33. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun. 2004;72: 4275–4278. pmid:15213173
  34. 34. Lau GW, Hassett DJ, Ran H, Kong F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trend Mol Med. 2004;10: 599–606. pmid:15567330
  35. 35. Wilson R, Pitt T, Taylor G, Watson D, MacDermot J, Sykes D, et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987;79: 221–229. pmid:3098783
  36. 36. Kanthakumar K, Taylor G, Tsang KW, Cundell DR, Rutman A, Smith S, et al. Mechanism of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun. 1993;61: 2848–2853. pmid:8390405
  37. 37. Caldwell CC, Chen Y, Goetzmann HS, Hao Y, Borchers MT, Hassett DJ, et al. Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis. Am J Pathol. 2009;175: 2473–2488. pmid:19893030
  38. 38. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988;56: 2515–2517. pmid:3137173
  39. 39. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol. 2007;7: 45. pmid:17521417
  40. 40. Cox CD. Role of pyocyanin in the acquisition of iron from transferrin. Infect Immun. 1986;52: 263–270. pmid:2937736
  41. 41. Wang Y, Wilks JC, Danhorn T, Ramos I, Croal L, Newman DK. Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J Bacteriol. 2011;193: 3606–3617. pmid:21602354
  42. 42. Minetti M, Mallozzi C, Scorza G, Scott MD, Kuypers FA, Lubin BH. Role of oxygen and carbon radicals in hemoglobin oxidation. Arch Biochem Biophys. 1992;302: 233–244.
  43. 43. Scannapieco F. Role of oral bacteria in respiratory infection. J Periodontol. 1999;70: 793–802. pmid:10440642
  44. 44. Nemec A, Pavlica Z, Svete AN, Erzen D, Crossley DA, Petelin M. Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1beta compartmentalization in lungs of mice after a single intratracheal inoculation with live Porphyromonas gingivalis. Exp Lung Res. 2009;35: 605–620. pmid:19842848
  45. 45. Winterbourne CC, McGrath BM, Carrell RW. Reactions involving superoxides and normal and unstable hemoglobin. Biochem J. 1976;155: 493–502. pmid:182128
  46. 46. Tsuruga M, Shikama K. Biphasic nature in the oxidation reaction of human oxyhemoglobin. Biochim Biophys Acta. 1997;133: 96–104.
  47. 47. Kosaka H, Imaizumi K, Imai K, Tyuma I. Stoichiometry of the reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta. 1979;581: 184–188. pmid:41590
  48. 48. Kimura H, Tsudzuki T, Murachi T. Proteolytic degradation of hemoglobin-haptoglobin complex by lysosomal enzymes from rat liver. J Biochem. 1975;77: 909–912. pmid:239934
  49. 49. Kimura H, Yamato S, Murachi T. Different susceptibilities to intracellular proteases of haemoglobin and haemoglobin-haptoglobin complex. Physiol Chem Phys. 1976;8: 101–106. pmid:10591
  50. 50. Crumton MJ, Polson A. A comparison of the conformation of sperm whale metmyoglobin with that of apomyoglobin. J Mol Biol. 1965;11: 722–729. pmid:14338782
  51. 51. Kawahara K, Kirshner AG, Tanford C. Dissociation of human CO-hemoglobin by urea, guanidine hydrochloride, and other reagents. Biochemistry. 1965;4: 1203–1213. pmid:5856626
  52. 52. Asher C, de Villiers KA, Egan TJ. Speciation of ferriprotoporphyrin IX in aqueous and mixed aqueous solution is controlled by solvent identity, pH, and salt concentration. Inorg Chem. 2009;48: 7994–8003. pmid:19572726
  53. 53. Smalley JW, Birss AJ, Withnall R, Silver J. Interactions of Porphyromonas gingivalis with oxyhaemoglobin and deoxyhaemoglobin. Biochem J. 2002;362: 239–245. pmid:11829761
  54. 54. Smith L, Rose B, Tingpej P, Hua Z, Conibear T, Manos J, et al. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J Med Microbiol. 2006;55: 1641–1644. pmid:17108265
  55. 55. Dias IH, Marshall L, Lambert PA, Chapple IL, Matthews JB, Griffiths HR. Gingipains from Porphyromonas gingivalis increase the chemotactic and respiratory burst-priming properties of the 77-amino-acid interleukin-8 variant. Infect Immun. 2008;76: 317–323. pmid:18025101
  56. 56. Mikolajczyk-Pawlinska J, Travis J, Potempa J. Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett. 1998;440: 282–286. pmid:9872387
  57. 57. Moelants EA, Loozen G, Mortier A, Martens E, Opdenakker G, Mizgalska D, et al. Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis. Infect Immun. 2014;82: 2511–2519. pmid:24686061
  58. 58. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, et al. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett. 1998;435: 45–48. pmid:9755856
  59. 59. Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation. 1990;14: 447–454. pmid:2166003
  60. 60. Marsh PD, McKee AS, McDermid AS. Effect of haemin on enzyme activity and cytotoxin production by Bacteroides gingivalis W50. FEMS Microbiol Lett. 1988;55: 87–92.
  61. 61. Smalley JW, Birss AJ, McKee AS, Marsh PD. Haemin-restriction influences haemin-binding, haemagglutination and protease activity of cells and extracellular membrane vesicles of Porphyromonas gingivalis W50. FEMS Microbiol Lett. 1991;69: 63–67. pmid:1664402
  62. 62. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax. 2010;65: 57–62. pmid:19846469
  63. 63. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109: 317–325. pmid:11827991
  64. 64. Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, et al. Sputum proteomics in inflammatory and suppurative respiratory disease. Am J Respir Crit Care Med. 2008;178: 444–452. pmid:18565957
  65. 65. Karunakaran T, Holt SC. Cloning of two distinct hemolysin genes from Porphyromonas (Bacteroides) gingivalis in Escherichia coli. Microb Pathog. 1993;15: 37–49. pmid:8412626
  66. 66. Deshpande RG, Khan MB. Purification and characterization of hemolysin from Porphyromonas gingivalis A7436. FEMS Microbiol Lett. 1999;176: 387–394. pmid:10427721
  67. 67. Li N, Yun P, Nadkarni MA, Ghadikolaee NB, Nguyen KA, Lee M, et al. Structure determination and analysis of a haemolytic gingipain adhesin domain from Porphyromonas gingivalis. Mol Microbiol. 2010;76: 861–873. pmid:20233299
  68. 68. Suzuki N, Fukamachi H, Arimoto T, Yamamoto M, Igarashi T. Contribution of hly homologs to the hemolytic activity of Prevotella intermedia. Anaerobe. 2012;18: 350–356. pmid:22554902
  69. 69. Zhang L, Levy A, Rifkind JM. Autoxidation of hemoglobin enhanced by dissociation into dimers. J Biol Chem. 1991;266: 24698–24701. pmid:1761565
  70. 70. Shikama K. The molecular mechanisms of autoxidation for myoglobin and haemoglobin: a venerable puzzle. Chem Rev. 1998;98: 1357–1372. pmid:11848936
  71. 71. Finnan S. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004;42: 5783–5792. pmid:15583313
  72. 72. O’Malley YQ, Abdalla MY, McCormick ML, Reszka KJ, Denning GM, Britigan BE. Subcellular localization of Pseudomonas pyocyanin cytotoxity in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;284: 420–430. pmid:12414438
  73. 73. Price-Whelan A, Dietrich LEP, Newman DK. Rethinking ‘secondary’ metabolism: physiological roles for phenazine antibiotics. Nature Chem Biol. 2006;2: 71–78.
  74. 74. Hassan HM, Fridovitch I. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch Biochem Biophys. 1979;196: 385–395. pmid:225995
  75. 75. Hassan HM, Fridovitch I. Mechanism of the antibiotic action of pyocyanine. J Bacteriol. 1980;141: 156–163. pmid:6243619
  76. 76. Mydel P, Takahashi Y, Yumoto H, Sztukowska M, Kubica M, Gibson FC, et al. Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. PLoS Pathog. 2006;2(7): e76. pmid:16895445
  77. 77. Smalley JW, Birss AJ, Silver J. The periodontal pathogen Porphyromonas gingivalis harnesses the chemistry of the μ-oxo bishaem of iron protoporphyrin IX to protect against hydrogen peroxide. FEMS Microbiol Lett. 2000;183: 159–164. pmid:10650220
  78. 78. Amano A, Ishimoto T, Tamagawa H, Shizukuishi S. Role of superoxide dismutase in resistance of Porphyromonas gingivalis to killing by polymorphonuclear leukocytes. Infect Immun. 1992;60: 712–714. pmid:1309723
  79. 79. Sugio S, Hiraoka BY, Yamakura F. Crystal structure of cambialistic superoxide dismutase from Porphyromonas gingivalis. Eur J Biochem. 2000;267: 3487–3495. pmid:10848964
  80. 80. Reszka KJ, O’Malley Y, McCormick ML, Denning GM, Britigan BE. Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide. Free Rad Biol Med. 2004;36: 1448–1459. pmid:15135182
  81. 81. Minas T, Greenman J, Schaffer AG. Effect of mucin, haemoglobin and collagen on the maximum specific growth rate, biomass and hydrolytic enzyme production of Porphyromonas gingivalis in continuous culture. Microb Ecol Health Dis. 1991;4: 311–318.
  82. 82. Minas T, Greenman J, Schaffer AG. The influence of haemin levels on growth and enzyme production by Porphyromonas gingivalis in continuous culture. Microbios. 1993;76: 105–114. pmid:8295552
  83. 83. Létoffé S, Redeker V, Wandersman C. Isolation and characterization of an extracellular haem-binding protein from Pseudomonas aeruginosa that shares function and sequence similarities with the Serratia marcescens HasA haemophore. Mol Microbiol. 1998;28: 1223–1234. pmid:9680211
  84. 84. Cornelis P. Iron uptake and metabolism in pseudomonads. Appl Microbiol Biotechnol. 2010;86: 1637–1645. pmid:20352420
  85. 85. Diaz PI, Rogers AH. The effect of oxygen on the growth and physiology of Porphyromonas gingivalis. Oral Microbiol Immunol. 2004;19: 88–94. pmid:14871347
  86. 86. Nakayama K. Rapid viability loss on exposure to air in a superoxide dismutase-deficient mutant of Porphyromonas gingivalis. J Bacteriol. 1994;176: 1939–1943. pmid:8144460
  87. 87. Sabra W, Kim E-J, Zeng A-P. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology. 2002;148: 3195–3202. pmid:12368453
  88. 88. Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev. 2002;54: 1425–1443. pmid:12458153
  89. 89. Schobert M, Jahn D. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol. 2010;300: 549–556. pmid:20951638
  90. 90. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, et al. Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections. PLoS Pathog. 2008;4(10): e1000184. pmid:18949036
  91. 91. Li Q, Pan C, Teng D, Lin L, Kou Y, Haase EM, et al. Porphyromonas gingivalis modulates Pseudomonas aeruginosa-induced apoptosis of respiratory epithelial cells through the STAT3 signaling pathway. Microbes Infect. 2014;16: 17–27. pmid:24140557
  92. 92. Pan Y, Teng D, Burke AC, Haase EM, Scannapieco FA. Oral bacteria modulate invasion and induction of apoptosis in Hep-2 cells by Pseudomonas aeruginosa. Microb Pathog. 2009;46: 73–79. pmid:19041936
  93. 93. Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev. 1994;13: 65–74. pmid:8117468
  94. 94. Pandey AV, Joshi SK, Tekwani BL, Chauhan VS. A colorimetric assay for heme in biological samples using 96-well plates. Anal Biochem. 1999;268: 159–161. pmid:10036177
  95. 95. Pike R, McGraw W, Potempa J, Travis J. Lysine- and arginine-specific proteinases from Porphyromonas gingivalis: Isolation and evidence for the existence of complexes with hemagglutinins. J Biol Chem. 1994;269: 406–411. pmid:8276827
  96. 96. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227: 680–685. pmid:5432063
  97. 97. Chen ZS, Potempa J, Polanowski A, WikstromII M, Travis J. Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem. 1992;267: 18896–18901. pmid:1527017